Clinical Research Directory
Browse clinical research sites, groups, and studies.
F 18 T807 Tau PET Imaging of Alzheimer's Disease
Sponsor: Tammie L. S. Benzinger, MD, PhD
Summary
A single-center, open-label baseline controlled imaging study designed to assess whether brain tau fibril uptake of flortaucipir as measured by PET correlates with cognitive status of individuals with and without brain tau fibrils.
Official title: F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
900
Start Date
2014-10-23
Completion Date
2024-12
Last Updated
2024-07-17
Healthy Volunteers
No
Conditions
Interventions
F 18 T807
Participants will receive a single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807. For those who cannot tolerate the full exam, participants will receive single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807.
Locations (1)
Washington University School of Medicine
St Louis, Missouri, United States